Type-I IFN immunity is essential for adequate protection, and harmful mutations as well as neutralizing auto-antibodies against IFN have seldom been identified, particularly in the severe manifestations of COVID-19 [19]. The gene discussed is IFNA1; the disease is COVID-19.